Nosa Med AB

NOSA · Nasdaq Stockholm · Healthcare

0.47SEK +7.2%last day

Price as of 2 October 2026

The price over the past year, with dividends: −32.4%

Performance

1 month

−5.2%

1 year

−32.4%

3 years, per year

−21.9%

5 years, per year

−26.0%

Largest fall, 3 years

−89.8%

Below the peak now

−98.7%

Volatility, 1 year

64.5%

Return with dividends reinvested.

Key figures

P/E

negative earnings

P/B

3.1

Dividend yield

0.0%

Return on equity

−20.4%

Net margin

−24.5%

Market value

12 m USD

Quality, value and trend

Where Nosa Med stands against every Nordic stock today. 100 is best.

Quality53

Profitability and a sound balance sheet over time. Better than 53% of Nordic stocks.

Value18

The price measured against earnings, assets and cash flow. Better than 18% of Nordic stocks.

Trend25

The price development over the past year. Better than 25% of Nordic stocks.

Combined16

Quality, value and trend together. Better than 16% of Nordic stocks.

About Nosa Med

Nosa Med AB is a company in healthcare, listed on Nasdaq Stockholm. The share trades in SEK. It has around 7 employees.

Nosa Plugs AB, a medical technology company, develops, manufactures, and sells intranasal breathing products in Sweden, Europe, North America, Oceania, and internationally. It offers NOSA smell training, a smell training medical device to improve the sense of smell for individuals with parosmia and hyposmia; NOSA odor control, which reduces bad odor; NOSA microbial control that reduces the exposure of viruses and bacteria by inhalation through the nose; NOSA Nozoil original, a moisturizing nasal spray for people suffering from dry nasal mucosa; and NOSA Cerevia, a nasal drug delivery platform for controlled administration of drugs.

See the full analysis in InvestWiser.

The accounts, dividends, 40 years of charts and the comparison with other stocks are in the app.

See the full analysis